NCT06499376

Brief Summary

At present, there is no universal early warning system implemented in all Basque hospitals, but there are previous experiences, sometimes based on models generated in other health systems. In this project we intend to provide a robust model, based on the analysis of patient data from three Basque hospitals, i.e. generated in our population. A three-phase study has been designed:

  1. 1.st phase: Derivation of the predictive model by means of a reprospective cohort study in which patients hospitalised at the Galdakao-Usansolo Hospital, Donostia University Hospital and Araba University Hospital will be recruited.
  2. 2.nd phase: Creation of an alarm system based on the probability of risk of clinical deterioration and implementation of the system in the electronic medical record (EHR) of the HGU, in the form of an "Action Guide".
  3. 3.rd phase: The model will be validated by comparing the percentages of clinical deterioration by means of a quasi-experimental intervention study, comparing the results of the HGU hospital where the system will be implemented, before and after the intervention and, on the other hand, with those of Hospital Universitario Donostia (HUD) and Hospital Universitario de Araba (HUA), where normal clinical practice will be followed, with an early warning system based on vital signs in HUD and clinical criteria in HUA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

2.4 years

First QC Date

June 26, 2024

Last Update Submit

July 10, 2024

Conditions

Keywords

Early warning system, clinical deterioration

Outcome Measures

Primary Outcomes (1)

  • Clinical deterioration

    death in admission or length of stay more than 12 hours in intensive or intermediary care unit (ICU).

    at least 24 hours after admission

Study Arms (2)

PATIENTS ADMITTED IN THE HOSPITAL IN 2019

Inclusion criteria: patients over 18 years of age hospitalised on conventional hospital wards, in medical and surgical departments or awaiting a bed during their stay in the emergency department. Exclusion criteria: patients with poor vital prognosis and DNR orders.

PATIENTS ADMITTED IN THE HOSPITAL IN 2021

Inclusion criteria: patients over 18 years of age hospitalised on conventional hospital wards, in medical and surgical departments or awaiting a bed during their stay in the emergency department. Exclusion criteria: patients with poor vital prognosis and DNR orders.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Medical and surgical services of the Galdakao-Usansolo Hospital (HGU), Donostia University Hospital (HUD) and Alava University Hospital (HUA). The HGU alone deals with 28592 admissions per year, of which 1088 are admitted to the intensive care unit.

You may qualify if:

  • patients over 18 years of age hospitalised on conventional hospital wards, in medical and surgical departments or awaiting a bed during their stay in the emergency department.

You may not qualify if:

  • patients with a poor prognosis for life and a DNR order.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Galdakao Usansolo

Galdakao, Bizkaia, 48960, Spain

Location

MeSH Terms

Conditions

Clinical Deterioration

Condition Hierarchy (Ancestors)

Disease ProgressionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Naia Mas, PhD

    Hospital Galdakao-Usansolo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
30 Days
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

June 26, 2024

First Posted

July 12, 2024

Study Start

August 1, 2019

Primary Completion

December 31, 2021

Study Completion

January 15, 2022

Last Updated

July 12, 2024

Record last verified: 2024-07

Locations